The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
361 - Has there been any code infraction of late that you can share to us? And what does PAAB do about it?
-
The stage 2 complaint decisions are published in our quarterly newsletter. Refer to the January 2014 newsletter for a report on the entire year of 2013. The January, April and July newsletters are also available for 2014 statistics. All PAAB quarterly newsletters can be accessed here: http://www.paab.ca/newsletters.htm Note that we only publish information about stage 2 complaints. Code infractions discovered in Stage 1 complaints, monitoring notices, and the review process are confidential.
